In addition, EGFR is localized to the basal layer of urothelial cells in normal urothelium, but is extensively present in both the luminal and basal layers in UCC [15], indicating that an EGFR-target intravesical treatment has potential for use in bladder cancer cell eradication. Here, EGFR is linked to urinary bladder cancer.